AstraZeneca has teamed up with Oracle to leverage AI and real-world data for identifying eligible patients and enhancing safety monitoring in clinical trials.
Oracle announced that it has signed a non-binding agreement with AstraZeneca to test the potential for AI and real world patient data to find trial-eligible patients faster, aimed at easing...
AstraZeneca is teaming up with Oracle to refine clinical research, in the latest artificial-intelligence partnership in the pharmaceutical industry.
AstraZeneca collaborates with Oracle to leverage AI and real-world data, aiming to enhance patient recruitment and safety monitoring in clinical trials.
Pharmaceutical company is working with Oracle to advance the use of AI and data analytics in medicine
First reported:
First saved on ClustZ:
Coverage updated:
We use cookies to improve your experience and analyze site traffic. By clicking "Accept", you agree to our use of cookies. See our Privacy Policy.